Allovate Therapeutics Appoints Bob Pomrenke as CEO
April 02, 2019 14:04 ET
|
Allovate, LLC
New York, April 02, 2019 (GLOBE NEWSWIRE) -- Allovate Therapeutics (“Allovate®”), a New York-based biotechnology company focused on improving treatment for allergies, is pleased to announce the...
Allergy Standards Ltd recognise OEKO TEX® Standard 100 as pathway to their Certification Program
March 19, 2019 08:54 ET
|
Allergy Standards Limited
New York, USA, March 19, 2019 (GLOBE NEWSWIRE) -- Allergy Standards Ltd. (ASL) announced today that they will accept OEKO TEX® Standard 100 certification as a pre-qualifier for the chemical...
Allergy Standards Ltd deepens footprint in the ‘Bay Area’ as Irish Minister for Health visits
March 15, 2019 18:31 ET
|
Allergy Standards Limited
SAN FRANCISCO, March 15, 2019 (GLOBE NEWSWIRE) -- Allergy Standards Limited (ASL) has been expanding its activities on the West Coast and a visit to San Francisco, Berkeley, and Los Angeles by its...
Allergy Standards’ Leadership Team Invited to Prestigious Scientific and Political High-Level Discussions
March 15, 2019 15:34 ET
|
Allergy Standards Limited
Boston, MA, March 15, 2019 (GLOBE NEWSWIRE) -- Allergy Standards Ltd (ASL), an international certification company which develops scientific testing protocols to reduce asthma and allergy triggers,...
Certification Program Attends the 2019 Science Foundation Ireland Award Ceremony in MIT
March 12, 2019 10:03 ET
|
Allergy Standards Limited
Boston, USA., March 12, 2019 (GLOBE NEWSWIRE) -- The leadership team of the asthma & allergy friendly® Certification Program, a joint venture between Allergy Standards Limited (ASL) and the...
Allovate Therapeutics Announces Grant of European Patent Covering Oral Mucosal Immunotherapy Platform
March 08, 2019 10:01 ET
|
Allovate, LLC
New York, March 08, 2019 (GLOBE NEWSWIRE) -- Allovate Therapeutics (“Allovate®”), a New York-based biotechnology company focused on improving treatment for allergies, is pleased to announce that the...
Intrommune Therapeutics Announces Grant of European Patent Covering Oral Mucosal Immunotherapy for Food Allergy
March 08, 2019 10:01 ET
|
Intrommune Therapeutics
New York, March 08, 2019 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biotechnology company developing a patient-friendly treatment platform for peanut and other food allergies, is...
Dr Joey DeCourcey invited Speaker at the 2019 Cleaning Products Conference Europe.
March 08, 2019 04:57 ET
|
Allergy Standards Limited
Dublin, Ireland, March 08, 2019 (GLOBE NEWSWIRE) -- Allergy Standards Limited (ASL) announced today that ASL’s Senior Scientific Officer, Dr Joey DeCourcey, will feature at the Cleaning Products...
Vystar Receives Second European Patent for Reduced Allergenicity Natural Rubber Latex
March 04, 2019 08:23 ET
|
Vystar Corp
Vystar’s Vytex® deproteinization method reduces allergenicity and odor,Manufacturing process uses less water, chemical and dyes for naturally, purer, whiter and stronger latex WORCESTER, Mass., March...
Umbrellux DAO Provides Solution to Americans Who Thought They Had an Allergy, but Really Suffer from Histamine Intolerance
February 14, 2019 09:00 ET
|
Umbrellux DAO
ANN ARBOR, Mich., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Only 10 percent of Americans have food allergies, but according to a new study in JAMA Network Open, almost double the number believe they do....